Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Non-Current Assets (2024 - 2026)

BioScience Health Innovations has reported Non-Current Assets over the past 3 years, most recently at $135401.0 for Q1 2026.

  • Quarterly Non-Current Assets rose 141.63% to $135401.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $135401.0 through Mar 2026, up 114.67% year-over-year, with the annual reading at $148523.0 for FY2025, 470.43% up from the prior year.
  • Non-Current Assets was $135401.0 for Q1 2026 at BioScience Health Innovations, down from $148523.0 in the prior quarter.
  • Over five years, Non-Current Assets peaked at $148523.0 in Q4 2025 and troughed at $7037.0 in Q3 2024.
  • The 3-year median for Non-Current Assets is $72101.0 (2025), against an average of $73891.0.
  • Year-over-year, Non-Current Assets soared 924.6% in 2025 and then soared 141.63% in 2026.
  • A 3-year view of Non-Current Assets shows it stood at $26037.0 in 2024, then soared by 470.43% to $148523.0 in 2025, then fell by 8.83% to $135401.0 in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Non-Current Assets are $135401.0 (Q1 2026), $148523.0 (Q4 2025), and $72101.0 (Q3 2025).